Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients

Critically ill patients often experience acute kidney injury and the need for renal replacement therapy in the course of their treatment in an intensive care unit (ICU). These patients are at an increased risk for candidiasis. Although there have been several reports of micafungin disposition during...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Vossen, M. G., Knafl, D., Haidinger, M., Lemmerer, R., Unger, M., Pferschy, S., Lamm, W., Maier-Salamon, A., Jäger, W., Thalhammer, F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2017
Soggetti:
Clinical Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527635/
https://ncbi.nlm.nih.gov/pubmed/28584142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02425-16
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi